Track and Trace System for Pharma Packaging

Counterfeit medicines continue to be one of the biggest global threats to patient safety. In 2024, over 6,400+ counterfeit pharmaceutical incidents were recorded worldwide, cutting into billions of dollars in losses and putting millions of patients at risk.

With strict regulatory deadlines in the US (DSCSA 2025), Europe (EU-FMD), and India’s QR Code mandate now active, pharmaceutical companies are under more pressure than ever to ensure end-to-end product traceability.

A track and trace solutions for anti-counterfeiting in pharmaceuticals, Packaging ensures that every manufactured unit—right from a single tablet carton to a full pallet—can be serialized, authenticated, monitored, and verified at every point in the supply chain.

Bar Code India’s expertise in serialization technology, packaging-line integration, and connected supply chain solutions supports pharma brands in achieving zero-compromise product security and complete regulatory compliance with minimal operational disruption.

Key Features of a Trace-and-Track System in Pharma Packaging

A trace-and-track system in pharmaceutical packaging possesses various essential characteristics that increase product safety and compliance throughout the entire supply chain. 

The key features are:

a. Serialisation: 

Each unit of medicine shall have a unique number that allows the production tracking to the distribution channel. Each unique identifier ensures that every unit can be tracked individually, thereby exposing counterfeiters who might introduce fake products into the market.

b. Aggregation: 

Products are grouped into a hierarchical structure, making it easy to track the products at any level, for example, cases or pallets. Aggregation simplifies the management of inventory and enhances visibility across the supply chain.

Units → Bundles → Shippers → Pallets

This structure:

• Reduces manual scanning
• Simplifies warehouse operations
• Enables rapid recall isolation
• Improves inventory visibility
• 
  

c. Data Management and Reporting: 

Track and trace systems handle millions of data points per batch. Strong back-end data management ensures accurate reporting and compliance with global regulatory systems such as EPCIS, NMVS, EMVS, and country-specific verification portals.

The system manages critical fields like:

• Batch/lot numbers
• Expiry dates
• Tamper-evidence checks
• Serialization events (commission, decommission, aggregation, shipment, receipt)

Accurate, real-time reporting prevents duplicate serials, mislabeling, and non-compliance penalties.

d. Real-Time Tracking and Monitoring: 

Companies can monitor product movement and environmental conditions in real time with the integration like:

• Barcodes: Fast, low-cost scanning points
• RFID: Automatic tracking without line-of-sight
• IoT Sensors: Temperature, humidity, and cold-chain insights

This ensures optimal product conditions and alerts stakeholders instantly in case of deviation.

 Explore the role of barcodes in pharma packaging.

How Trace and Track Systems Work in Pharma Packaging

A trace-and-track system preserves a product’s identity from the moment the first pack is printed to the final point of patient dispensing. It is not a simple barcode workflow, it is a multi-layer digital infrastructure connecting packaging machinery (L1), line management (L2), site servers (L3), enterprise systems (L4), and external regulatory portals (L5).

The process below reflects how modern serialization architecture operates on real packaging floors.

1. Serialization

Each saleable unit receives a globally unique product identifier, typically a GS1-standardized GTIN, serial number, expiry, and batch, rendered as a India-mandated QR code.

On the line:

• The L2 system generates or fetches serial numbers in real time.
• Printers apply codes at high speeds without compromising readability.
• Vision cameras validate print placement, contrast, quiet zones, and decode rates.

A failed code is rejected automatically, and the L2 controller updates EPCIS events to ensure no invalid pack enters circulation. Serialization becomes the digital passport regulators use to validate authenticity.

2. Tracking

As the product moves through the supply chain, every touchpoint generates a track event:

• Case packers
• Warehouse inbound/outbound gates
• Third-party logistics hubs
• Export clearance points
• Hospital and pharmacy dispensaries

Each scan generates time stamps, GPS-mapped location, operator info, and event types (commission, pack, ship, receive, decommission). This transforms the supply chain from a “black box” into a continuously monitored movement log, allowing immediate anomaly detection such as:

• Route deviations
• Unexpected handovers
• Temperature-excursion alerts
• Diversion into unapproved markets

Tracking ensures not just visibility, but real-time supply chain integrity.

3. Traceability

All transactional and movement events funnel into enterprise EPCIS repositories, creating a tamper-proof product history.

Traceability enables:

• End-to-end investigation during recalls
• Instant verification during regulator audits
• Root-cause analysis for supply disruptions
• Proof-of-pedigree for distributors

From L1 scans to the final L5 reporting layer, the system maintains a unified, regulator-ready audit trail. Nothing depends on manual logs; every data point is system-captured to preserve accuracy.

4. Checking

On the production line, checking is not just reading a barcode, it is a multi-layer visual and logical validation process:

• OCR/OCV verifies expiry dates, batch numbers, and human-readable text.
• Vision algorithms confirm code placement, contrast, data integrity, and serialization sequence.
• Packaging integrity checks ensure correct cartons, leaflets, and label positioning.

Each validation reduces downstream rework and improves first-time-right performance, critical for maintaining line OEE in serialized environments.

5. Coding

Beyond serialization, additional coding supports the aggregation hierarchy that regulators and distributors expect.

This includes:

• Case-level and pallet-level codes
• Parent-child mappings that describe exactly which units sit inside which shipper
• L1 equipment generating and printing unique container identifiers (SSCC codes)
• L2 software confirming the digital relationship and signing EPCIS “pack” events

Coding builds the structured tree that allows an entire pallet to be verified with one scan, eliminating manual counting errors and reducing warehouse cycle times.

6. Verification

Verification is the front-line defense against counterfeits, parallel trade, and tampering.

At any point for factory QA, wholesaler, hospital pharmacy, or patient, scanning the serialized or QR code fetches:

• Product authenticity
• Packaging lineage
• Supply chain trail
• Shipment history
• Decommission status

A mismatch, duplicate serial, or invalid status triggers immediate escalation.

Verification ensures that only legitimate, regulator-approved products reach the patient, protecting both brand reputation and public health.

Integration with ERP and Supply Chain Systems

A modern trace-and-track system integrates tightly with:

• ERP platforms (SAP, Oracle, Microsoft)

• Warehouse Management Systems (WMS)

• Manufacturing Execution Systems (MES)

• Regulatory reporting portals (DSCSA, EMVS, NMVS)

This eliminates data silos and ensures effortless information flow between production, quality, regulatory, and distribution teams. The result: fewer manual processes, fewer discrepancies, and stronger audit readiness.

Role of Technologies Like Barcodes, RFID, and IoT Sensors

a. Barcodes: 

They are printed on packaging and scanned at various points in the supply chain, which captures real-time information about product movement.

b. RFID (Radio-Frequency Identification): 

RFID tags improve tracking capabilities through the automatic identification of products without direct line-of-sight scanning, thus accelerating processes.

c. IoT Sensors: 

These sensors monitor environmental conditions such as temperature and humidity during transportation to ensure that products remain within safe parameters.

Benefits of Trace and Track Systems in Pharma Packaging

A trace-and-track system in pharmaceutical packaging has several advantages. Some of these advantages are ensuring patient safety, transparency in the supply chain, and compliance with regulatory requirements. A trace-and-track system is critical in preventing counterfeit drugs from reaching the market, easy recalls, and enhancing customer trust in pharmaceutical brands.

1. Preventing Counterfeit Drugs in the Market:

The trace and track system can combat counterfeit drugs since it will assign every product with distinctive identifiers. It will assist stakeholders in monitoring whether the drugs are original or not, from the production to the consumption level.

2. Streamlining Recalls and Improving Inventory Management:

In cases of product recall, trace and track systems allow for prompt identification and isolation of recalled batches in the market. Such capability reduces patient health risks and, more so, helps in inventory management through real-time information about stock positions and whereabouts. With a trace-and-track system in place, a company can really streamline supply chain processes and save on operational costs.

3 . Regulatory Compliance:

Pharmaceutical companies have to follow strict rules set by regulators. The trace and trace system makes sure that the right information is collected about where a product came from, how it was stored, and any other information that could lead to a danger or a penalty for not following the rules.

4 . Developing Customer Trust and Brand Reputation:

Trace and track systems enhance significant customer trust because of increased transparency in the supply chain. Consumers trust brands when they can verify the authenticity and safety of the medication. Such a reputation for quality and safety may help enhance customer loyalty with a competitive advantage in the marketplace.

In summary, pharmaceutical companies implement trace and track systems for pharma packaging to protect patients, ensure efficiency, comply with regulatory agencies, and maintain brand integrity.

Challenges in Implementing Trace and Track Systems in Pharma Packaging

Trace and track systems may require substantial investment, which can be a barrier for small to mid-sized pharmaceutical companies that deal with limited funds and infrastructure. The implementation of trace and track systems becomes difficult for such organisations because of insufficient budget allocation for the necessary technology upgrade, training, and system integration. Ongoing maintenance operational costs can further aggravate their strained financial capabilities.

1. Preventing Counterfeit Drugs (A Global & Local Supply-Chain Defence Layer)

Counterfeiting is a $200+ billion global problem, and India is one of the largest target markets due to the sheer volume of exported and domestic drug circulation. Serialization provides each saleable unit, bundle, carton, and pallet with a tamper-proof digital identity, generated at Line Level (L1/L2), aggregated correctly at L3, and verified instantly at L4/L5.

Key impacts:

• QR/Datamatrix codes allow regulators, distributors, and pharmacies to instantly authenticate products before they move further.
• Counterfeit infiltration at repacking, wholesale, or hospital distribution levels drops significantly.
• In global shipments, EPCIS-compliant data ensures receiving countries can verify the product’s entire chain of custody.
• Brand owners gain real-time intelligence on suspicious scans, duplicate codes, and supply-chain leakages.

Result: Lower risk, safer patients, and stronger market credibility.

2. Streamlined Recalls, Batch Isolation & Inventory Intelligence

Without serialization, recalls can take days to weeks, and companies end up pulling more products than necessary. With trace-and-track, batch isolation becomes a 2-minute process, not a 2-day crisis.

Expanded benefits:

• Precise geo-level isolation: Identify which distributor, region, or pharmacy holds affected stock.
• Controlled recalls: Only the impacted units are recalled, reducing financial loss by 40–70%.
• Real-time inventory: Serialization doubles as a live inventory management system across plants, CMO partners, wholesalers, and depots.
• Expiry and FEFO enforcement: Manufacturers understand expiry distribution patterns and can proactively prevent market ageing.
• Parallel trade monitoring: Detect diversion or leakage when products scan outside intended geographies.

This shifts serialization from a cost center to a supply-chain intelligence engine.

3. Regulatory Compliance Across Global Markets (Non-Negotiable)

Compliance today spans the US DSCSA, EU FMD, Russia CryptoCodes, Saudi Arabia Tatmeen, UAE Tatmeen, India DAVA replacement + QR code mandate, and dozens of country-specific schemas. A robust L1–L5 setup ensures you:

• Generate and manage serial numbers, aggregation data, and EPCIS files in the mandated formats.
• Integrate seamlessly with NMVS, EMVS, DSCSA Partner Exchanges, and country-specific portals.
• Avoid penalties, shipment delays, border seizures, blacklisting, or loss of export licenses.
• Stay audit-ready with a complete digital chain-of-custody log of every unit.

A compliant traceability system doesn’t just avoid fines, it guarantees uninterrupted access to high-value markets.

4. Strengthening Customer & Pharmacy Trust (End-User Transparency)

Today’s pharmacists and end consumers actively distrust market circulation due to counterfeit incidents. Serialization transforms this:

• A simple smartphone scan validates product legitimacy.
• Pharmacies gain confidence in stocking the brand because authenticity is verifiable.
• Patients feel safer consuming a medicine they can digitally validate.
• Manufacturers receive anonymized scan data showing where and how products are consumed.

This builds brand trust, loyalty, and long-term retention, especially in chronic therapies where patient stakes are high.

5. Internal Operational Efficiency & OEE Gains

Traceability improves internal manufacturing performance when implemented properly:

• Automated aggregation reduces manual workload and human error.
• Packaging lines experience improved OEE because serialization cameras, vision systems, and rejection modules enforce First-Time-Right production.
• Line operators spend less time on paperwork and more on efficient throughput.
• Paperless reporting accelerates QA approvals, batch release, and dispatch processes.
• Real-time dashboards expose bottlenecks: bad print quality, misalignment errors, or equipment causing serialization rejects.

This is the hidden but extremely valuable benefit pharma manufacturers realize only after adoption.

6. Better Collaboration With CMOs & Distribution Partners

Serialization ensures every Contract Manufacturing Organization and every logistics partner works with the same data truth:

• Serial number issuance and reconciliation become seamless.
• Cannot ship without compliant EPCIS/Lot data.
• Distributors gain centralized visibility of incoming and outgoing stock.
• Manufacturers gain kill/commission event logs ensuring total control.
• 
  

End result: zero blind spots across the extended supply chain.

Global Regulatory Standards for Pharma Packaging

Global pharmaceutical packaging standards are are binding, data-driven frameworks that dictate how every single unit of medicine must be serialized, aggregated, traced, authenticated, and digitally verified across its entire lifecycle.

These regulations serve three non-negotiable objectives:

1. Protect patient safety by eliminating counterfeit or tampered medicines
2. Enable end-to-end supply chain visibility using GS1 data standards, EPCIS event reporting, and unique identifiers
3. Enforce accountability at each node of the supply chain through strict reporting, verification, and audit requirements

The global shift toward digital traceability means packaging is no longer just a physical layer, it's a regulatory, data-capture, and compliance-critical touchpoint integrated tightly with L1–L5 traceability systems.

Overview of Key Regulations Across Major Regions

a. USA: Drug Supply Chain Security Act (DSCSA)

DSCSA mandates full unit-level traceability for all prescription drugs sold in the U.S. It requires manufacturers, repackagers, wholesale distributors, and dispensers to share interoperable electronic data that captures every transaction, from packaging line activation to pharmacy-level verification.

Key mandates include:

• Unique serial numbers (GTIN + serial + lot + expiry) on every sellable unit

• PI (Product Identifier) encoded in a 2D DataMatrix following GS1 standards

• EPCIS-based data exchange between all supply chain partners

• Aggregation from unit → bundle → case → pallet to maintain parent–child hierarchy

• Complete transaction history (TH), transaction information (TI), and transaction statements (TS)

2023 Enforcement:

As of November 2023, DSCSA moved into full enforcement. Manufacturers without end-to-end serialization, aggregation, and electronic traceability systems risk:

• Product quarantine or rejection
• Supply chain disruption due to unverifiable shipments
• Heavy fines for non-compliance
• Loss of access to the U.S. market

This regulation essentially forces pharma companies to operate with digitally mature packaging lines and synchronized L1–L5 track-and-trace infrastructure.

b. EU: Falsified Medicines Directive (FMD)

The European FMD is designed to lock down the pharmaceutical supply chain using mandatory safety features and real-time verification.

Key requirements include:

• Unique Identifier (UI) encoded in a GS1-compliant 2D DataMatrix
• Tamper Evident Device (TED) on every pack, ensuring the pack cannot be opened without visible damage
• End-of-supply-chain verification at every dispensing point via the European Medicines Verification System (EMVS)
• Serialization data uploaded to the EU Hub, with strict alignment between national repositories
• Real-time alerts and automated product decommissioning during dispensing

FMD is one of the strictest frameworks worldwide because it not only demands serialization but forces verification at the last mile, closing the loop between manufacturer and pharmacy.

Non-compliance exposes companies to:

• National authority intervention
• Product withdrawal from supply chain nodes
• Legal consequences for falsification or incomplete data submission
• Blacklisting from EMVS, meaning products cannot be dispensed in the EU

c. Other Major Markets (China, India, Brazil, Middle East, ANVISA, TGA)

China

China’s regulations are built around high-volume serialization and mandatory government reporting. Manufacturers must upload product event data to government-run systems, covering:

• Selection of approved serialization formats

• Line-level controls and serialization status reporting

• Pack, carton, and pallet-level aggregation

• In-country traceability and post-market surveillance

China’s regulations are rigid and frequently updated, requiring manufacturers to maintain adaptable serialization systems.

India

India’s regulatory landscape has undergone a massive shift due to soaring counterfeit risks. Key mandates include:

• Mandatory QR codes on primary and secondary packaging for specific drug categories
• Encoded data must include manufacturing date, expiry date, batch number, license details, and unique code
• For export drugs, mandatory barcodes + aggregation linked to the DAVA portal
• Stepwise expansion of QR requirements across therapeutic classes

The Indian mandate is especially critical because of India’s role as a global manufacturing hub, making traceability mandatory for both domestic and export markets.

Deadlines and Penalties for Non-Compliance

Across all regions, regulatory bodies have shifted from “recommendation” to absolute enforcement, with legally binding deadlines.

Examples:

• DSCSA (US): November 2023 – full serialization + EPCIS interoperability

• EU FMD: Immediate verification requirements enforced with system-level audits

• India: Progressive QR mandates expanding annually

• China: Periodic compliance checks and production halts for non-compliant lines

Penalties include:

• Seizure or rejection of non-serialized batches

• Heavy monetary fines

• Suspension of licenses

• Market access bans

• Supply chain disruption due to partner rejection

• Damage to brand credibility and regulatory trust

In pharma, non-compliance is not just a regulatory failure, it's a public health violation that can collapse market access overnight

Future Trends in Trace and Track for Pharma

Advancements in technology are transforming pharma track-and-trace systems. Innovative tools such as blockchain, artificial intelligence (AI), and the Internet of Things (IoT) are predicted to be drivers of the change.

1. Blockchain for Enhanced Traceability:

● Decentralized ledgers ensure tamper-proof transaction records.

● Prevents fraud and increases supply chain transparency.

2. AI and Machine Learning for Predictive Analytics:

● AI helps in detecting anomalies and predicting supply chain disruptions.

● Machine learning optimizes inventory management.

3 . Expansion of IoT Integration for Real-Time Monitoring:

● Smart sensors track temperature, humidity, and location.

● Enhances cold chain logistics for vaccines and biologics.

Conclusion

A trace-and-track system for pharma packaging works toward ensuring drug safety, regulatory compliance, and supply chain efficiency. By tracing a suite of advanced serialisation and tracking technologies and deploying data management systems, pharmaceutical manufacturers can fight counterfeit drugs, streamline recalls,s and foster customer trust, thus enabling the industry to act. Invest today in a trace-and-track pharmacy system to ensure a safe and transparent pharmaceutical world tomorrow. 

Looking to enhance your track-and-trace capabilities? Explore cutting-edge solutions here.

FAQs

1. What changes are required at the packaging line to enable serialization?

Serialization requires integrating L1 devices (printers, cameras, scanners) with L2 line management software. This means installing high-resolution printers for DataMatrix codes, vision systems for code verification, reject mechanisms, and ensuring the line can handle slower speeds if necessary. Line balancing, buffer conveyors, and quality gates must also be recalibrated.

2. How does aggregation work at the bundle, carton, and pallet levels?

Aggregation establishes a parent–child hierarchy. Each serialized unit is linked to a bundle code; bundles are linked to shippers; shippers are linked to pallets. Scanners at each station capture these relationships and transmit them to the L3 site server. Any mismatch or missing child unit results in immediate rejection or manual inspection.

3. What happens if a code fails verification on the line?

Failed codes are automatically rejected through pneumatic ejectors. The L2 software logs the failure, assigns the unit as “decommissioned,” and prevents it from moving downstream. Operators must check print quality, camera alignment, or potential hardware issues if reject rates spike.

4. How is EPCIS data generated during packaging?

EPCIS events are triggered at each critical operation: commissioning, aggregation, shipment, and receipt. The L2 system sends event data to the L3 site server, which formats it according to GS1 EPCIS 1.2/2.0 standards. The L4 enterprise server then distributes EPCIS data to regulators, partners, or verification hubs.

5. How do we handle rework or re-aggregation after a packaging error?

Rework requires decommissioning the affected serial numbers, printing new serials, and reconstructing the parent–child hierarchy. Operators must scan every unit manually to ensure no broken aggregation links exist. All rework must be logged as regulatory events.

6. How does Track & Trace impact line speed (OEE)?

Serialization typically introduces micro-stoppages due to camera validations, print inspections, and reject mechanisms. Aggregation can cause bottlenecks if operators are slow with handling. OEE drops by ~5–12% initially, but stabilizes after optimization and training.

7. What is the difference between commissioning, aggregation, and shipping events?

• Commissioning: Assigning a serial number to a unit and marking it active

• Aggregation: Linking units → bundles → cases → pallets

• Shipping: Generating EPCIS “shipping events” and moving the batch to the warehouse

Each event has different data fields and compliance rules.

8. What systems are responsible for data flow from line to regulator?

• L1: Printers/scanners

• L2: Line serialization systems

• L3: Site repository

• L4: Enterprise repository

• L5: Regulatory or market reporting (DSCSA, EMVS, DAVA, China codes)

Each level must successfully handshake before data moves upward.

9. What is a “bad aggregation” and how is it corrected?

Bad aggregation occurs when a unit is scanned into the wrong case or when a unit is missed. The case must be “exploded” in the system, rescanned manually, and re-aggregated. Physical counts must match digital counts to avoid compliance exceptions.

10. How do QA teams verify a serialized batch?

QA checks for:

• Correct DataMatrix print quality (ISO/IEC 15415 grading)

• Serial number range integrity

• EPCIS event consistency

• Aggregation hierarchy integrity

• No duplicate or re-used serials
• 
  

Batch release is impossible without validated serialization reports.